Exploring decaprenyl-phosphoryl ribose epimerase (DprE1) as a validated target for TB drug discovery: Assay development, high-throughput screening and search for novel DprE1 inhibitor scaffolds

Projektinformationen

DPRETB

ID Finanzhilfevereinbarung: 252802

Abgeschlossenes Projekt

Startdatum 1 Mai 2010

Enddatum 30 April 2012

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 174 065,20

EU-Beitrag € 174 065,20

Koordiniert durch

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Switzerland